It is Time That Health Authorities Promote the Use of Oxygen-ozone Therapy as an Integrative Therapy of Orthodox Drugs

Velio Bocci

Department of Biotechnologies, Chemistry and Pharmacy, University of Siena, Italy.

Emma Borrelli *

Department of Medical Biotechnologies, University of Siena, Italy.

*Author to whom correspondence should be addressed.


Abstract

Ozone is a very reactive gas and is toxic for the respiratory system but, under precise rules, it can be therapeutically useful for human disease with a chronic oxidative stress. An unfavorable combination of factors such as a wrong dogma, the fact that ozone is one of the worst troposphere pollutants and past misuse of ozone have led to a poor consideration of ozone therapy. However, basic and clinical work, developed during the last two decades, clarified both the biochemical and molecular mechanisms of action of ozone in biology and medicine. A judicious dose of ozone dissolved in blood immediately triggers a cascade of well defined chemical compounds acting on multiple cellular targets according to well-known biochemical and molecular pathways. Ozone therapy is proving to be very useful in the dry form of age-related macular degeneration (AMD), cardiovascular diseases, chronic obstructive pulmonary disease (COPD), cerebral diseases and healing disorders, where conventional medicine appears insufficient and too expensive. It is time that World Health Authorities abandon prejudice and skepticism and start to take advantage of an integrative medical application able to help the majority of world population.

Keywords: Ozone therapy, ozone tolerance, ischemic diseases, age-related macular degeneration, lung diseases, type II diabetes, cerebral diseases


How to Cite

Bocci, Velio, and Emma Borrelli. 2015. “It Is Time That Health Authorities Promote the Use of Oxygen-Ozone Therapy As an Integrative Therapy of Orthodox Drugs”. Journal of Advances in Medicine and Medical Research 10 (4):1-9. https://doi.org/10.9734/BJMMR/2015/17684.

Downloads

Download data is not yet available.